Cord Blood America Inc  

(Public, OTCMKTS:CBAI)   Watch this stock  
Find more results for OTC:CBAI
-0.00020 (-7.41%)
Feb 24 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.00 - 0.00
52 week 0.00 - 0.01
Open 0.00
Vol / Avg. 513,191.00/515,371.00
Mkt cap 3.24M
P/E 31.25
Div/yield     -
EPS 0.00
Shares 1.27B
Beta 0.40
Inst. own 30%
Mar 28, 2017
Q4 2016 Cord Blood America Inc Earnings Release (Estimated) Add to calendar

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 18.00% 8.33%
Operating margin 13.44% 13.38%
EBITD margin - 14.95%
Return on average assets 16.35% 11.58%
Return on average equity 110.87% -
Employees 15 -
CDP Score - -


1857 Helm Dr
LAS VEGAS, NV 89119-3911
United States - Map
+1-702-9147250 (Phone)

Website links


Cord Blood America, Inc. (CBAI), through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. CBAI's subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. CBAI and its subsidiaries engage in the various business activities, such as CBAI and Cord specialize in providing private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord's operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.

Officers and directors

Stephen David Morgan Interim President, Vice President, General Counsel, Secretary
Age: 38
Adrian Pertierra Director
Age: 43
David A. Sandberg Director
Age: 42
Anthony Snow Director
Timothy G. McGrath Independent Director
Age: 51